Feedback / Questions
IkT-148009 - Inhibikase, Clintrex
https://www.prnewswire.com/news-releases/inhibikase-therapeutics-receives-fda-clearance-to-begin-evaluation-of-ikt-148009-in-parkinsons-patients-301340976.html
Jul 26, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next